MedPath

A Study to Evaluate the Effectiveness of a Topical Unani Formulation Compared to Luliconazole 1 Percent Ointment in Treating Bahaq (Pityriasis Versicolor)

Phase 2
Not yet recruiting
Conditions
Pityriasis versicolor,
Registration Number
CTRI/2025/05/087906
Lead Sponsor
Government Nizamia Tibbi College and General Hospital
Brief Summary

Bahaq (Pityriasis versicolor) is a superficial fungal infection caused by Malassezia furfur, commonly affecting young adults. Though effective treatments exist in conventional medicine, challenges persist due to frequent recurrences, pigmentary changes, and potential side effects of oral antifungals, including hepatotoxicity and rare cardiac complications. The condition often leads to cosmetic concerns and emotional distress. Unani medicine has long used herbomineral remedies for Bahaq, but lacks scientific validation. This study aims to evaluate the safety and efficacy of a topical Unani formulation in managing Bahaq Aswad using modern clinical tools.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Age group above 16 to 45 years Sex: Both males & females Patient with any of the sign and symptoms of Bahaq (Pityriasis Versicolor) Hyper pigmented macule, Erythema, Pruritus on the lesion, Scaling / Desquamation.
  • Presence of Malassezia furfur in the scrapings of the lesion.
Exclusion Criteria

Patient with serious co-morbid medical condition and other fungal infection Participant who had received any systemic or topical antimycotic therapy within month of start of study Significant Pulmonary/Cardiovascular/ Hepato-renal Dysfunction Known cases of Immunocompromised states (HIV, AIDS, etc.) Malignancies Patient not willing to attend treatment schedule regularly Person, Individual with any active Psychiatric illness KoH mount test negative.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mycological cure rate of KOH examination of skin scrap (Direct Microscopy) at the end of 45 days.45 Days
Secondary Outcome Measures
NameTimeMethod
Improvement in subjective parameters (Hypopigmentation, Scaling & Itching) of skin lesions evaluated byan arbitrary grading scale, Total Sign & Symptom Score (TSSS) assessed on four point scale (0 absent, 1 mild, 2 moderate, 3 severe)

Trial Locations

Locations (1)

Government Nizamia Tibbi College and General Hospital, Charminar

🇮🇳

Hyderabad, TELANGANA, India

Government Nizamia Tibbi College and General Hospital, Charminar
🇮🇳Hyderabad, TELANGANA, India
Dr Mehsan Barawaz
Principal investigator
9346061003
mehsanbarawaz@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.